SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-09-13 17:03
Tx date 2024-09-13
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+800,000 vol
2,576,860
Filed 2024-09-05 13:14
Tx date 2024-09-05
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,000
+50,000 vol
$0.10 each
1,362,313
Filed 2024-07-18 17:34
Tx date 2024-07-18
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+150,000 vol
626,200
Filed 2024-07-18 17:33
Tx date 2024-07-18
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$30,000
+300,000 vol
$0.10 each
1,312,313
Filed 2024-07-15 17:04
Tx date 2024-07-03
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
36 - Conversion or exchange
$5,983
+55,609 vol
$0.1076 each
1,012,313
Filed 2024-06-14 12:40
Tx date 2024-04-12
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants

-452,429 vol
476,200
Filed 2024-04-15 12:34
Tx date 2024-04-12
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants

+452,429 vol
Filed 2024-05-17 13:11
Tx date 2024-05-16
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$3,689
+38,834 vol
$0.095 each
956,704
Filed 2024-05-17 13:10
Tx date 2024-05-16
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Performance Share Units
57 - Exercise of rights

-38,834 vol
189,274
Filed 2024-05-17 13:08
Tx date 2024-05-16
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Performance Share Units
58 - Expiration of rights

-38,834 vol
228,108
Filed 2024-04-15 12:34
Tx date 2024-04-12
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants

+452,429 vol
1,381,058
Filed 2024-04-02 16:44
Tx date 2024-04-02
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$3,530
+37,163 vol
$0.095 each
917,870
Filed 2024-04-02 16:42
Tx date 2024-04-02
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-37,163 vol
535,343
Filed 2024-01-02 16:53
Tx date 2023-12-29
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
36 - Conversion or exchange
$2,695
+24,222 vol
$0.1113 each
880,707
Filed 2023-11-30 17:33
Tx date 2023-11-28
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+1,450,000 vol
1,776,860
Filed 2023-11-30 17:31
Tx date 2023-11-28
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+550,000 vol
572,506
Filed 2023-11-30 17:29
Tx date 2023-11-29
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,750
+50,000 vol
$0.075 each
856,485
Filed 2023-10-11 13:54
Tx date 2023-10-10
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+476,200 vol
928,629
Filed 2023-10-11 13:52
Tx date 2023-10-10
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures 12% Unsecured Convertible Debenture
11 - Acquisition or disposition carried out privately
$
+$100 vol
$1,000 each
$100
Filed 2023-10-11 13:50
Tx date 2020-04-07
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures 12% Unsecured Convertible Debenture
00 - Opening Balance-Initial SEDI Report
Filed 2023-05-01 13:37
Tx date 2023-04-28
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$3,368
+25,910 vol
$0.13 each
806,485
Filed 2023-05-01 13:36
Tx date 2023-04-28
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-25,910 vol
22,506
Filed 2023-04-05 14:47
Tx date 2023-04-05
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$9,900
+100,000 vol
$0.099 each
780,575
Filed 2023-03-31 13:46
Tx date 2023-03-30
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase

-412,400 vol
326,860
Filed 2023-03-31 13:42
Tx date 2023-03-30
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,067.13
-11,857 vol
$0.09 each
680,575
Filed 2023-03-31 13:41
Tx date 2023-03-30
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$3,158
+37,162 vol
$0.085 each
692,432
Filed 2023-03-31 13:39
Tx date 2023-03-30
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-37,162 vol
48,416
Filed 2022-11-10 15:38
Tx date 2022-11-10
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,750
+50,000 vol
$0.135 each
655,270
Filed 2022-09-20 15:44
Tx date 2022-09-20
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,900
+40,000 vol
$0.1225 each
605,270
Filed 2022-09-15 16:26
Tx date 2022-09-15
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$12,150
+90,000 vol
$0.135 each
565,270
Filed 2022-09-13 16:47
Tx date 2022-09-09
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,650
+30,000 vol
$0.155 each
475,270
Filed 2022-05-05 12:17
Tx date 2022-05-02
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,936.32
-8,068 vol
$0.24 each
445,270
Filed 2022-05-05 12:16
Tx date 2022-05-02
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$6,736
+25,909 vol
$0.26 each
453,338
Filed 2022-05-05 12:15
Tx date 2022-05-02
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-25,909 vol
85,578
Filed 2022-04-25 14:01
Tx date 2022-04-22
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
97 - Other

-100,000 vol
739,260
Filed 2022-04-25 13:59
Tx date 2022-04-20
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Restricted Performance Share Units
56 - Grant of rights

+111,486 vol
266,942
Filed 2022-04-25 13:58
Tx date 2022-04-20
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+111,487 vol
111,487
Filed 2022-04-25 13:57
Tx date 2020-04-07
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2022-04-25 13:56
Tx date 2022-04-20
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+50,000 vol
839,260
Filed 2021-05-03 18:55
Tx date 2021-04-28
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Restricted Performance Share Units
30 - Acquisition or disposition under a purchase/ownership plan

+155,456 vol
155,456
Filed 2021-05-03 18:54
Tx date 2020-04-07
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Restricted Performance Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-03 18:54
Tx date 2021-04-28
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$321,620
+200,000 vol
$1.61 each
789,260
Filed 2021-04-08 18:08
Tx date 2021-03-01
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants

+40,000 vol
427,429
Filed 2021-04-08 18:07
Tx date 2021-03-01
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants

-40,000 vol
452,429
Filed 2020-10-30 17:42
Tx date 2020-10-29
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus

+40,000 vol
492,429
Filed 2020-10-30 17:41
Tx date 2020-10-29
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$52,000
+80,000 vol
$0.65 each
387,429
Filed 2020-06-29 17:23
Tx date 2020-04-07
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
452,429
Filed 2020-06-29 17:22
Tx date 2020-04-07
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
589,260
Filed 2020-06-29 17:21
Tx date 2020-04-07
$WLLW
Willow Biosciences Inc.
Savile, Christopher Kenneth
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
307,429